Evicenter
MarkdownMedical informationP&T meetings
Darovasertib (IDE196)

First-line metastatic uveal melanoma, in combination with crizotinib

Also known as LXS196
Manufacturer
IDEAYA Biosciences
Launch
Not announced
Last updated
206 sources

Product information and disease descriptionProduct descriptionProduct informationDrug/Drug, drug/disease interactions

Effects of other drugs on Darovasertib

4 evidence topics · 2 sources

Clinical drug interaction studies with darovasertib as the affected drug

No evidence found.

Crizotinib label: strong and moderate CYP3A inhibitors and grapefruit